King, Rubio Urge FDA for Guidance on Stronger, Cheaper Drug Manufacturing Process
September 23, 2024
September 23, 2024
WASHINGTON, Sept. 23 -- Sen. Angus S. King Jr., I-Maine, issued the following news release:
Senator Angus King (I-ME) and Marco Rubio (R-FL) are urging the Food and Drug Administration (FDA) to clarify its approval process for pharmaceutical companies considering advanced manufacturing technologies (AMTs) such as continuous manufacturing, a means of production that involves a more uninterrupted process. In a letter to FDA Commissioner Dr. Robert Califf, the senators encouraged the F . . .
Senator Angus King (I-ME) and Marco Rubio (R-FL) are urging the Food and Drug Administration (FDA) to clarify its approval process for pharmaceutical companies considering advanced manufacturing technologies (AMTs) such as continuous manufacturing, a means of production that involves a more uninterrupted process. In a letter to FDA Commissioner Dr. Robert Califf, the senators encouraged the F . . .